A detailed history of Kings Path Partners LLC transactions in Pfizer Inc stock. As of the latest transaction made, Kings Path Partners LLC holds 2,850 shares of PFE stock, worth $84,787. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,850
Holding current value
$84,787
% of portfolio
0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$25.26 - $29.6 $71,991 - $84,360
2,850 New
2,850 $79.7 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $167B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Kings Path Partners LLC Portfolio

Follow Kings Path Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kings Path Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kings Path Partners LLC with notifications on news.